Everett brings extensive experience addressing complex commercialization challenges and optimizing product performance across a wide range of therapeutic areas, including neurology, psychiatry, ophthalmology, nephrology, dermatology, oncology, and rare disease. Everett takes a collaborative approach, applying insightful analysis and compelling storytelling to support teams in defining their strategic goals and developing achievable solutions.

Everett’s project portfolio encompasses a blend of global and US launch strategy development, launch process enhancements, market access strategy, and operations support, and initiatives focused on organizational effectiveness and in-line product acceleration. In aggregate, Everett has successfully supported launch planning and/or execution for over 15 assets.

Prior to joining Herspiegel, Everett’s work at ZS Associates included qualitative and quantitative market research, go-to-market planning, and sales and marketing strategy. He holds a BA from the University of North Carolina—Chapel Hill and an MBA from Duke’s Fuqua School of Business.